Using Diagnostic Tools to Stage Breast Cancer

Evaluation of Multimodality Breast Imaging: Lesion Staging

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00367666

Enrollment

400

Registered

2006-08-23

Start date

2002-03-01

Completion date

2027-03-12

Last updated

2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

Interventions

DEVICEMRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Women recently diagnosed with Breast Cancer * Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania

Exclusion criteria

* Contraindications to MRI * previously diagnosed with breast cancer (in the smae breast) within the past 5 years * Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy. * Pregnant women

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAbass Alavi, MD

University of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026